Medartis Holding AG
MDRSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $225 | $212 | $183 | $160 |
| % Growth | 6% | 16% | 14.4% | – |
| Cost of Goods Sold | $46 | $44 | $47 | $38 |
| Gross Profit | $179 | $168 | $135 | $122 |
| % Margin | 79.5% | 79% | 74.1% | 76% |
| R&D Expenses | $43 | $26 | $24 | $18 |
| G&A Expenses | $39 | $34 | $32 | $26 |
| SG&A Expenses | $141 | $132 | $126 | $103 |
| Sales & Mktg Exp. | $102 | $98 | $94 | $77 |
| Other Operating Expenses | -$13 | $1 | $0 | $0 |
| Operating Expenses | $171 | $158 | $137 | $111 |
| Operating Income | $8 | $9 | -$2 | $11 |
| % Margin | 3.5% | 4.3% | -1% | 6.9% |
| Other Income/Exp. Net | -$5 | -$7 | -$5 | -$3 |
| Pre-Tax Income | $2 | $2 | -$7 | $8 |
| Tax Expense | -$1 | $1 | -$1 | $1 |
| Net Income | $4 | $1 | -$6 | $7 |
| % Margin | 1.6% | 0.3% | -3.2% | 4.3% |
| EPS | 0.26 | 0.051 | -0.49 | 0.58 |
| % Growth | 413.8% | 110.3% | -184.5% | – |
| EPS Diluted | 0.26 | 0.051 | -0.49 | 0.58 |
| Weighted Avg Shares Out | 14 | 12 | 12 | 12 |
| Weighted Avg Shares Out Dil | 14 | 12 | 12 | 12 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $0 |
| Interest Expense | $5 | $2 | $5 | $1 |
| Depreciation & Amortization | $22 | $13 | $18 | $16 |
| EBITDA | $30 | $25 | $16 | $25 |
| % Margin | 13.4% | 11.6% | 8.9% | 15.9% |